pharma · Autoimmune Epilepsy · OPTN
Option Therapeutics
OYE Therapeutics is a pharma organization headquartered in CARSON CITY, NV, USA. It trades on NYSE under ticker OPTN. Primary therapeutic focus areas include Autoimmune Epilepsy. NovaPharmaNews links 1 clinical program(s
CARSON CITY, NV, USA HQ
2023 Founded
2 Employees
Public company Type
OPTN · NYSE Ticker
Company details
- Status
- Public
- HQ
- CARSON CITY, NV, USA
- Founded
- 2023
- Employees
- 2
- Programs
- 1
- Drugs
- 1
- Patents
- 10
Intravenous Immunoglobulin
Phase 3 · small molecule · Autoimmune Epilepsy
Intravenous Immunoglobulin for Autoimmune Epilepsy is a Phase 3 program (small_molecule) at Option Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code 15-005649
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Option Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Autoimmune Epilepsy
- Status
- terminated
- Trials
- 1